Filed: 2/14/2024ACC: 0000950123-24-002504
📋 What this filing means
OMEGA FUND MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 14 equity positions with a total reported market value of $123.44M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
14
Positions
$123.44M
Total AUM (reported)
34.17M
Total Shares
Allocation by class
COMMON STOCK$100.27M81.2%
COMMON STOCK CLASS A$22.76M18.4%
WARRANT$403.8K0.3%
Portfolio Concentration
Top 3$77.02M62.4%
4–10$41.25M33.4%
11–25$5.17M4.2%
Top 3 weight
62.4%
Top 10 weight
95.8%
Voting Authority Distribution
Total shares with voting rights: 34.17M
Sole
Full voting authority
34.17M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole14
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings14
Rows:
Lexeo Therapeutics
SOLEShares2.16M
TypeSH
Market value$28.96M
23.46%
Sole
2.16M
Shared
0.00
None
0.00
Replimune Group
SOLEShares3M
TypeSH
Market value$25.30M
20.50%
Sole
3M
Shared
0.00
None
0.00
Nuvation Bio
SOLEShares15.07M
TypeSH
Market value$22.76M
18.44%
Sole
15.07M
Shared
0.00
None
0.00
enGene Holdings Inc.
SOLEShares1.13M
TypeSH
Market value$10.44M
8.46%
Sole
1.13M
Shared
0.00
None
0.00
Morphic Holding
SOLEShares309.85K
TypeSH
Market value$8.95M
7.25%
Sole
309.85K
Shared
0.00
None
0.00
Spruce Biosciences
SOLEShares2.16M
TypeSH
Market value$6.33M
5.13%
Sole
2.16M
Shared
0.00
None
0.00
Kronos Bio
SOLEShares3.82M
TypeSH
Market value$4.77M
3.87%
Sole
3.82M
Shared
0.00
None
0.00
Ikena Oncology
SOLEShares2.25M
TypeSH
Market value$4.43M
3.59%
Sole
2.25M
Shared
0.00
None
0.00
Sana Biotechnology, Inc.
SOLEShares843.75K
TypeSH
Market value$3.44M
2.79%
Sole
843.75K
Shared
0.00
None
0.00
Theseus Pharmaceuticals
SOLEShares711.48K
TypeSH
Market value$2.88M
2.33%
Sole
711.48K
Shared
0.00
None
0.00
Immunic Inc
SOLEShares1.79M
TypeSH
Market value$2.68M
2.17%
Sole
1.79M
Shared
0.00
None
0.00
Syros Pharmaceuticals
SOLEShares251.27K
TypeSH
Market value$1.96M
1.59%
Sole
251.27K
Shared
0.00
None
0.00
enGene Holdings Inc.
SOLEShares475.08K
TypeSH
Market value$403.8K
0.33%
Sole
475.08K
Shared
0.00
None
0.00
Senti Biosciences, Inc.
SOLEShares195.79K
TypeSH
Market value$129.2K
0.10%
Sole
195.79K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Lexeo TherapeuticsSOLE | Common Stock | 2.16M | SH | $28.96M 23.46% | 2.16M | 0.00 | 0.00 |
Replimune GroupSOLE | Common Stock | 3M | SH | $25.30M 20.50% | 3M | 0.00 | 0.00 |
Nuvation BioSOLE | Common Stock Class A | 15.07M | SH | $22.76M 18.44% | 15.07M | 0.00 | 0.00 |
enGene Holdings Inc.SOLE | Common Stock | 1.13M | SH | $10.44M 8.46% | 1.13M | 0.00 | 0.00 |
Morphic HoldingSOLE | Common Stock | 309.85K | SH | $8.95M 7.25% | 309.85K | 0.00 | 0.00 |
Spruce BiosciencesSOLE | Common Stock | 2.16M | SH | $6.33M 5.13% | 2.16M | 0.00 | 0.00 |
Kronos BioSOLE | Common Stock | 3.82M | SH | $4.77M 3.87% | 3.82M | 0.00 | 0.00 |
Ikena OncologySOLE | Common Stock | 2.25M | SH | $4.43M 3.59% | 2.25M | 0.00 | 0.00 |
Sana Biotechnology, Inc.SOLE | Common Stock | 843.75K | SH | $3.44M 2.79% | 843.75K | 0.00 | 0.00 |
Theseus PharmaceuticalsSOLE | Common Stock | 711.48K | SH | $2.88M 2.33% | 711.48K | 0.00 | 0.00 |
Immunic IncSOLE | Common Stock | 1.79M | SH | $2.68M 2.17% | 1.79M | 0.00 | 0.00 |
Syros PharmaceuticalsSOLE | Common Stock | 251.27K | SH | $1.96M 1.59% | 251.27K | 0.00 | 0.00 |
enGene Holdings Inc.SOLE | Warrant | 475.08K | SH | $403.8K 0.33% | 475.08K | 0.00 | 0.00 |
Senti Biosciences, Inc.SOLE | Common Stock | 195.79K | SH | $129.2K 0.10% | 195.79K | 0.00 | 0.00 |